Skip to main content
Therapeutic Advances in Medical Oncology logoLink to Therapeutic Advances in Medical Oncology
. 2021 May 17;13:17588359211019229. doi: 10.1177/17588359211019229

Corrigendum to “FGFR aberrations increase the risk of brain metastases and predict poor prognosis in metastatic breast cancer patients”

PMCID: PMC8132079  PMID: 34394747

Xie N, Tian C, Wu H, et al. FGFR aberrations increase the risk of brain metastases and predict poor prognosis in metastatic breast cancer patients. Ther Adv Med Oncol 2020; 12: 1-15. DOI: 10.1177/1758835920915305.

In the above-referenced article, the funding number of Zhe-Yu Hu’s Changsha Science and Technology Project Program should be kq1901076. Updated Funding detail is given below:

Funding

The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Hunan Provincial Natural Science Youth Foundation Project Grant No.2019JJ50356 (Recipient: Zhe-Yu Hu); Hunan Provincial Health and Sanitation Committee Project Grant No. C2019070 (Recipient: Zhe-Yu Hu); Key Research Program in Hunan Social Development Grant No. 2019SK2032 (Recipient: Zhe-Yu Hu); Changsha Science and Technology Project Program No. kq1901076 (Recipient: Zhe-Yu Hu).


Articles from Therapeutic Advances in Medical Oncology are provided here courtesy of SAGE Publications

RESOURCES